These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28798096)

  • 1. Activation of tissue plasminogen activator by metastasis-inducing S100P protein.
    Clarke CJ; Gross SR; Ismail TM; Rudland PS; Al-Medhtiy M; Santangeli M; Barraclough R
    Biochem J; 2017 Sep; 474(19):3227-3240. PubMed ID: 28798096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the C-Terminal Lysine of S100P in S100P-Induced Cell Migration and Metastasis.
    Ismail TM; Gross SR; Lancaster T; Rudland PS; Barraclough R
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
    Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
    Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients.
    Wang G; Platt-Higgins A; Carroll J; de Silva Rudland S; Winstanley J; Barraclough R; Rudland PS
    Cancer Res; 2006 Jan; 66(2):1199-207. PubMed ID: 16424059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V; Medved L; Lijnen HR; Ingham K
    J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
    Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
    Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioredoxin-1 promotes colorectal cancer invasion and metastasis through crosstalk with S100P.
    Lin F; Zhang P; Zuo Z; Wang F; Bi R; Shang W; Wu A; Ye J; Li S; Sun X; Wu J; Jiang L
    Cancer Lett; 2017 Aug; 401():1-10. PubMed ID: 28483515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerization and divalent ion binding properties of the S100P protein: a Ca2+/Mg2+-switch model.
    Gribenko AV; Makhatadze GI
    J Mol Biol; 1998 Oct; 283(3):679-94. PubMed ID: 9784376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100P promotes pancreatic cancer growth, survival, and invasion.
    Arumugam T; Simeone DM; Van Golen K; Logsdon CD
    Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A; Kramer MD; Schirrmacher V; Brunner G
    Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA.
    Urano T; Suzuki Y
    J Biomed Biotechnol; 2012; 2012():208108. PubMed ID: 23118500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers.
    Jankun J; Merrick HW; Goldblatt PJ
    J Cell Biochem; 1993 Oct; 53(2):135-44. PubMed ID: 8227186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin.
    Sorrell AM; Shand JH; Tonner E; Gamberoni M; Accorsi PA; Beattie J; Allan GJ; Flint DJ
    J Biol Chem; 2006 Apr; 281(16):10883-9. PubMed ID: 16505491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
    Jiang H; Hu H; Tong X; Jiang Q; Zhu H; Zhang S
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):1-9. PubMed ID: 21947242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration.
    Du M; Wang G; Ismail TM; Gross S; Fernig DG; Barraclough R; Rudland PS
    J Biol Chem; 2012 May; 287(19):15330-44. PubMed ID: 22399300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
    Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
    Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent l-lysine-containing domains.
    Gonzalez-Gronow M; Fiedler JL; Farias Gomez C; Wang F; Ray R; Ferrell PD; Pizzo SV
    Biochem Biophys Res Commun; 2017 Aug; 490(3):855-860. PubMed ID: 28648598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers.
    Sharma MC
    Int J Cancer; 2019 May; 144(9):2074-2081. PubMed ID: 30125343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.